Cargando…

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus

Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantovani, Alessandro, Rigolon, Riccardo, Pichiri, Isabella, Bonapace, Stefano, Morani, Giovanni, Zoppini, Giacomo, Bonora, Enzo, Targher, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628831/
https://www.ncbi.nlm.nih.gov/pubmed/28981521
http://dx.doi.org/10.1371/journal.pone.0185459
_version_ 1783268947643072512
author Mantovani, Alessandro
Rigolon, Riccardo
Pichiri, Isabella
Bonapace, Stefano
Morani, Giovanni
Zoppini, Giacomo
Bonora, Enzo
Targher, Giovanni
author_facet Mantovani, Alessandro
Rigolon, Riccardo
Pichiri, Isabella
Bonapace, Stefano
Morani, Giovanni
Zoppini, Giacomo
Bonora, Enzo
Targher, Giovanni
author_sort Mantovani, Alessandro
collection PubMed
description Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between NAFLD and heart block. We have retrospectively evaluated a hospital-based cohort of 751 patients with type 2 diabetes discharged from our Division of Diabetes and Endocrinology during years 2007–2014. Standard electrocardiograms were performed on all patients. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced hepatic fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis markers. Overall, 524 (69.8%) patients had NAFLD and 202 (26.9%) had heart block (defined as at least one block among first-degree atrio-ventricular block, second-degree block, third-degree block, left bundle branch block, right bundle branch block, left anterior hemi-block or left posterior hemi-block) on electrocardiograms. Patients with NAFLD had a remarkably higher prevalence of any persistent heart block than those without NAFLD (31.3% vs. 16.7%, p<0.001); this prevalence was particularly increased among those with higher FIB-4 score. NAFLD was associated with a threefold increased risk of prevalent heart block (adjusted-odds ratio 3.04, 95% CI 1.81–5.10), independently of age, sex, hypertension, prior ischemic heart disease, hemoglobin A1c, microvascular complication status, use of medications and other potentially confounding factors. In conclusion, this is the largest cross-sectional study to show that NAFLD and its severity are independently associated with an increased risk of prevalent heart block in hospitalized patients with type 2 diabetes.
format Online
Article
Text
id pubmed-5628831
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56288312017-10-20 Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus Mantovani, Alessandro Rigolon, Riccardo Pichiri, Isabella Bonapace, Stefano Morani, Giovanni Zoppini, Giacomo Bonora, Enzo Targher, Giovanni PLoS One Research Article Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between NAFLD and heart block. We have retrospectively evaluated a hospital-based cohort of 751 patients with type 2 diabetes discharged from our Division of Diabetes and Endocrinology during years 2007–2014. Standard electrocardiograms were performed on all patients. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced hepatic fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis markers. Overall, 524 (69.8%) patients had NAFLD and 202 (26.9%) had heart block (defined as at least one block among first-degree atrio-ventricular block, second-degree block, third-degree block, left bundle branch block, right bundle branch block, left anterior hemi-block or left posterior hemi-block) on electrocardiograms. Patients with NAFLD had a remarkably higher prevalence of any persistent heart block than those without NAFLD (31.3% vs. 16.7%, p<0.001); this prevalence was particularly increased among those with higher FIB-4 score. NAFLD was associated with a threefold increased risk of prevalent heart block (adjusted-odds ratio 3.04, 95% CI 1.81–5.10), independently of age, sex, hypertension, prior ischemic heart disease, hemoglobin A1c, microvascular complication status, use of medications and other potentially confounding factors. In conclusion, this is the largest cross-sectional study to show that NAFLD and its severity are independently associated with an increased risk of prevalent heart block in hospitalized patients with type 2 diabetes. Public Library of Science 2017-10-05 /pmc/articles/PMC5628831/ /pubmed/28981521 http://dx.doi.org/10.1371/journal.pone.0185459 Text en © 2017 Mantovani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mantovani, Alessandro
Rigolon, Riccardo
Pichiri, Isabella
Bonapace, Stefano
Morani, Giovanni
Zoppini, Giacomo
Bonora, Enzo
Targher, Giovanni
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title_full Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title_fullStr Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title_full_unstemmed Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title_short Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
title_sort nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628831/
https://www.ncbi.nlm.nih.gov/pubmed/28981521
http://dx.doi.org/10.1371/journal.pone.0185459
work_keys_str_mv AT mantovanialessandro nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT rigolonriccardo nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT pichiriisabella nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT bonapacestefano nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT moranigiovanni nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT zoppinigiacomo nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT bonoraenzo nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus
AT targhergiovanni nonalcoholicfattyliverdiseaseisassociatedwithanincreasedriskofheartblockinhospitalizedpatientswithtype2diabetesmellitus